{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:58:49Z","timestamp":1790809129198,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.cancergencyto.2010.08.022","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T10:25:04Z","timestamp":1292322304000},"page":"215-221","source":"Crossref","is-referenced-by-count":11,"title":["GSTT1 copy number gain is a poor predictive marker for escalated-dose imatinib treatment in chronic myeloid leukemia: genetic predictive marker found using array comparative genomic hybridization"],"prefix":"10.1016","volume":"203","author":[{"given":"Youngil","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hyo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hyun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunkyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeoung-Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Kyun","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Don","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Jin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Suk","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooseop","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung Kook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Hun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeun-Jun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonyang","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2010.08.022_bib1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"Baccarani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1182\/asheducation-2006.1.211","article-title":"ABL kinase inhibitor therapy for CML: baseline assessments and response monitoring","author":"Hughes","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.hoc.2004.03.001","article-title":"Clinical resistance to imatinib: mechanisms and implications","volume":"18","author":"Hochhaus","year":"2004","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib4","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"IRIS investigators. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib5","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood-2004-03-1114","article-title":"Detection of BCR-ABL kinase mutations in CD34+ cells from chronic myelogenous leukemia patients in complete cytogenetic remission on imatinib mesylate treatment","volume":"105","author":"Chu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib6","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1182\/blood-2002-12-3659","article-title":"Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib","volume":"101","author":"Corbin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1034\/j.1600-0609.2003.00046.x","article-title":"Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib","volume":"70","author":"Morel","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib8","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0092-8674(03)00190-9","article-title":"Mechanisms of autoinhibition and STI-571\/imatinib resistance revealed by mutagenesis of BCR-ABL","volume":"112","author":"Azam","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2002-05-1451","article-title":"Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia","volume":"101","author":"Kantarjian","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/cncr.24066","article-title":"Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase","volume":"115","author":"Kantarjian","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00277-010-0910-8","article-title":"Phase IV study evaluating efficacy of escalated dose of imatinib in chronic myeloid leukemia patients showing suboptimal response to standard dose imatinib","volume":"89","author":"Koh","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib12","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/cncr.23355","article-title":"Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulations","volume":"112","author":"Lee","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib13","doi-asserted-by":"crossref","first-page":"17765","DOI":"10.1073\/pnas.0407979101","article-title":"Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA","volume":"101","author":"Barrett","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"37 Suppl","key":"10.1016\/j.cancergencyto.2010.08.022_bib14","article-title":"Array comparative genomic hybridization and its applications in cancer","author":"Pinkel","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2006.10.021","article-title":"Recurrent genomic alterations with impact on survival in colorectal cancer identified by genome-wide array comparative genomic hybridization","volume":"131","author":"Kim","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib16","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1093\/bioinformatics\/bti357","article-title":"ArrayCyGHt: a Web application for analysis and visualization of array-CGH data","volume":"21","author":"Kim","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib17","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/bioinformatics\/bth418","article-title":"Analysis of array CGH data: from signal ratio to gain and loss of DNA regions","volume":"20","author":"Hup\u00e9","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CTmethod","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib19","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/gcc.20303","article-title":"Genomewide screening of DNA copy number changes in chronic myelogenous leukemia with the use of high-resolution array-based comparative genomic hybridization","volume":"45","author":"Hosoya","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/gcc.10173","article-title":"Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over-representation","volume":"37","author":"Gribble","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/asheducation-2009.1.477","article-title":"Monitoring disease response to tyrosine kinase inhibitor therapy in CML","author":"Hughes","year":"2009","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/10428190310001623900","article-title":"Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes","volume":"45","author":"Specchia","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2010.08.022_bib23","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.leukres.2007.02.003","article-title":"Increased frequencies of glutathione- S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia","volume":"31","author":"Bajpai","year":"2007","journal-title":"Leuk Res"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810004851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460810004851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T07:58:43Z","timestamp":1544083123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460810004851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0165460810004851"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2010.08.022","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}